Article

January is Glaucoma Awareness Month

January is National Glaucoma Awareness Month, and in observance, the four principal investigators of the Glaucoma Research Foundation (GRF) Catalyst for a Cure consortium will present a scientific overview of recent research advances.

San Francisco

-January is National Glaucoma Awareness Month, and in observance, the four principal investigators of the Glaucoma Research Foundation (GRF) Catalyst for a Cure consortium will present a scientific overview of recent research advances as part of the organization’s benefit Jan. 28 at the Palace Hotel in San Francisco. The event also will celebrate the group’s 31st anniversary.

“Early detection and treatment is the only way to prevent further vision loss” associated with the disease, said Thomas M. Brunner, GRF president and chief executive officer. “At GRF, we believe that a cure is attainable in the future, and National Glaucoma Awareness Month helps us raise awareness for potential treatments and cures available to glaucoma patients today.”

For more information about the event, contact Craig Palmer at 415/986-3162 or

cpalmer@glaucoma.org

.

Founded in 1978 in San Francisco, the GRF claims to be the oldest national foundation dedicated to preventing vision loss from glaucoma. The organization invests in research, education, and support with the ultimate goal of finding a cure.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
© 2025 MJH Life Sciences

All rights reserved.